CSF and laboratory analysis (tumor markers)

Handbook of Clinical Neurology

Volumn 104, Issue , 2012, Pages 143-148

  Preusser, Matthias ^a   Hainfellner, Johannes A ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855541524     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52138-5.00011-6     Document Type: Chapter

References (47)

1. Abrey L.E., Batchelor T.T., Ferreri A.J., et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 2005, 23:5034-5043.
2. Adachi N. Beta-2-microglobulin levels in the cerebrospinal fluid: their value as a disease marker. A review of the recent literature. Eur Neurol 1991, 31:181-185.
3. Allen J.C., Nisselbaum J., Epstein F., et al. Alphafetoprotein and human chorionic gonadotropin determination in cerebrospinal fluid. An aid to the diagnosis and management of intracranial germ-cell tumors. J Neurosurg 1979, 51:368-374.
4. Baehring J.M., Hochberg F.H., Betensky R.A., et al. Immunoglobulin gene rearrangement analysis in cerebrospinal fluid of patients with lymphoproliferative processes. J Neurol Sci 2006, 247:208-216.
5. Batchelor T., Loeffler J.S. Primary CNS lymphoma. J Clin Oncol 2006, 24:1281-1288.
6. Biesterfeld S., Bernhard B., Bamborschke S., et al. DNA single cell cytometry in lymphocytic pleocytosis of the cerebrospinal fluid. Acta Neuropathol (Berl) 1993, 86:428-432.
7. Burger B., Zimmermann M., Mann G., et al. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 2003, 21:184-188.
8. Calaminus G., Vesterling-Horner D., Bokkerink J.P., et al. The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors. Klin Padiatr 1991, 203:246-250.
9. Calaminus G., Bamberg M., Baranzelli M.C., et al. Intracranial germ cell tumors: a comprehensive update of the European data. Neuropediatrics 1994, 25:26-32.
10. Calaminus G., Andreussi L., Garre M.L., et al. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sgct). Klin Padiatr 1997, 209:222-227.
11. Calaminus G., Bamberg M., Harms D., et al. AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. Neuropediatrics 2005, 36:71-77.
12. Chamberlain M.C. Neoplastic meningitis. J Clin Oncol 2005, 23:3605-3613.
13. Chamberlain M.C., Kormanik P.A., Glantz M.J. A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases. Neuro-oncol 2001, 3:42-45.
14. Chang C.H., Housepian E.M., Herbert C. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 1969, 93:1351-1359.
15. Cibas E.S., Malkin M.G., Posner J.B., et al. Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid. Am J Clin Pathol 1987, 88:570-577.
16. DeAngelis L.M. Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 1998, 38:245-252.
17. Ekstein D., Ben-Yehuda D., Slyusarevsky E., et al. CSF analysis of igh gene rearrangement in CNS lymphoma: relationship to the disease course. J Neurol Sci 2006, 247:39-46.
18. Ferreri A.J., Reni M. Prognostic factors in primary central nervous system lymphomas. Hematol Oncol Clin North Am 2005, 19:629-649. vi.
19. Ferreri A.J., Blay J.Y., Reni M., et al. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol 2003, 21:266-272.
20. Fischer L., Jahnke K., Martus P., et al. The diagnostic value of cerebrospinal fluid pleocytosis and protein in the detection of lymphomatous meningitis in primary central nervous system lymphomas. Haematologica 2006, 91:429-430.
21. Fouladi M., Gajjar A., Boyett J.M., et al. Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol 1999, 17:3234-3237.
22. Glantz M.J., Cole B.F., Glantz L.K., et al. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 1998, 82:733-739.
23. Glass J.P., Melamed M., Chernik N.L., et al. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 1979, 29:1369-1375.
24. Gleissner B., Chamberlain M.C. Neoplastic meningitis. Lancet Neurol 2006, 5:443-452.
25. Gobel U., Calaminus G., Schneider D.T., et al. Management of germ cell tumors in children: approaches to cure. Onkologie 2002, 25:14-22.
26. Hansen P.B., Kjeldsen L., Dalhoff K., et al. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement. Acta Neurol Scand 1992, 85:224-227.
27. Hegde U., Filie A., Little R.F., et al. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood 2005, 105:496-502.
28. Hovestadt A., Henzen-Logmans S.C., Vecht C.J. Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis. Br J Cancer 1990, 62:653-654.
29. Hug A., Storch-Hagenlocher B., Haas J., et al. Single-cell PCR analysis of the immunoglobulin heavy-chain CDR3 region for the diagnosis of leptomeningeal involvement of B-cell malignancies using standard cerebrospinal fluid cytospins. J Neurol Sci 2004, 219:83-88.
30. Jeffery G.M., Frampton C.M., Legge H.M., et al. Cerebrospinal fluid B2-microglobulin levels in meningeal involvement by malignancy. Pathology 1990, 22:20-23.
31. Jubran R.F., Finlay J. Central nervous system germ cell tumors: controversies in diagnosis and treatment. Oncology (Williston Park) 2005, 19:705-711.
32. Kaplan J.G., DeSouza T.G., Farkash A., et al. Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 1990, 9:225-229.
33. Kortmann R.D., Kuhl J., Timmerman B., et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 2000, 46:269-279.
34. Nuckel H., Novotny J.R., Noppeney R., et al. Detection of malignant haematopoietic cells in the cerebrospinal fluid by conventional cytology and flow cytometry. Clin Lab Haematol 2006, 28:22-29.
35. Oehmichen M. Cerebrospinal Fluid Cytology - An Introduction and Atlas 1976, Thieme, Stuttgart.
36. Packer R.J., Siegel K.R., Sutton L.N., et al. Leptomeningeal dissemination of primary central nervous system tumors of childhood. Ann Neurol 1985, 18:217-221.
37. Pollack I.F., Hurtt M., Pang D., et al. Dissemination of low grade intracranial astrocytomas in children. Cancer 1994, 73:2869-2878.
38. Renshaw A.A., Hughes J.H., Wang E., et al. Leukemia/lymphoma in cerebrospinal fluid: distinguishing between cases that performed well and poorly in the College of American Pathologists Interlaboratory Comparison Program in Non-gynecologic Cytology. Arch Pathol Lab Med 2006, 130:1762-1765.
39. Rhodes C.H., Glantz M.J., Glantz L., et al. A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer 1996, 77:543-548.
40. Schneider D.T., Calaminus G., Gobel U. Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood. Pediatr Hematol Oncol 2001, 18:11-26.
41. Shinoda J., Yamada H., Sakai N., et al. Placental alkaline phosphatase as a tumor marker for primary intracranial germinoma. J Neurosurg 1988, 68:710-720.
42. Storch-Hagenlocher B., Haas J., Vogt-Schaden M.E., et al. Molecular analysis of the CDR3 encoding region of the immunoglobulin heavy chain locus in cerebrospinal fluid cells as a diagnostic tool in lymphomatous meningitis. Ann Neurol 2000, 47:211-217.
43. Strik H., Luthe H., Nagel I., et al. Automated cerebrospinal fluid cytology: limitations and reasonable applications. Anal Quant Cytol Histol 2005, 27:167-173.
44. Urbanits S., Griesmacher A., Hopfinger G., et al. FACS analysis - a new and accurate tool in the diagnosis of lymphoma in the cerebrospinal fluid. Clin Chim Acta 2002, 317:101-107.
45. van Oostenbrugge R.J., Hopman A.H., Arends J.W., et al. The value of interphase cytogenetics in cytology for the diagnosis of leptomeningeal metastases. Neurology 1998, 51:906-908.
46. Wasserstrom W.R., Glass J.P., Posner J.B. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982, 49:759-772.
47. Zeltzer P.M., Boyett J.M., Finlay J.L., et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase II study. J Clin Oncol 1999, 17:832-845.